A solid-phase, long-acting CCR5 monoclonal antibody for HIV transmission

Ended Project Grant Awarded Last action

Award ID
R01AI154559
Recipient
Awarding agency
Obligated
$10,400,939

Award facts

Assistance listing
93.855 Allergy and Infectious Diseases Research
Completion date
Funding
  • $8,524,902.45 Federal
  • $1,876,037.00 Non-federal
Place of performance
Oregon, USA

Award details come from USAspending.gov.

Transactions

Action Federal Non-federal Date
Amendment -$54,748 $0
Amendment $992,151 $0
Amendment $51,885 $0
Amendment $51,885 $0
Amendment $924,035 $0
Amendment $924,035 $0
Amendment $924,035 $0
Amendment $945,533 $0
Amendment $945,533 $945,533
Amendment $930,504 $0
Amendment $930,504 $930,504
Original award $959,550 $0
Show all 12

Subawards

Subrecipient Amount Awarded
University Of Massachusetts Medical School A Solid-Phase, Long-Acting CCR5 Monoclonal Antibody for HIV Transmission $62,376
Elektrofi, Inc. $54,779

Quick answers

Who received award R01AI154559?

R01AI154559 was awarded to Oregon Health & Science University by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on July 23, 2020.

How much is award R01AI154559 worth?

$10,400,939 has been obligated on R01AI154559: $8,524,902 in federal funding and $1,876,037 in non-federal funding.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award